✦ LIBER ✦

Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer : A phase 1 trial

✍ Scribed by Allyson J. Ocean; Kenneth L. Pennington; Michael J. Guarino; Arif Sheikh; Tanios Bekaii-Saab; Aldo N. Serafini; Daniel Lee; Max W. Sung; Seza A. Gulec; Stanley J. Goldsmith; Timothy Manzone; Michael Holt; Bert H. O'Neil; Nathan Hall; Alberto J. Montero; John Kauh; David V. Gold; Heather Horne; William A. Wegener; David M. Goldenberg

Book ID: 112067193
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 995 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27592

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary Results of a Phase 1 Study o

Preliminary Results of a Phase 1 Study of Hyperfractionated Low-Dose Radiation Therapy (RT) as a Chemotherapy Sensitizer in Combination With Gemcitabine (G) and Erlotinib (E) in Advanced Pancreatic Cancer

✍ Konski, A.A.; Meyer, J.; Philip, P.; Shields, A.; Hall, M.; Choi, M.; Duncan, G. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB